# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA1605605 | Y-27632 | Imax | < | 50 | % | ALA4417742 | % | Homo sapiens | |||
2. | ALA4559701 | 3 | Ki | = | 560 | nM | ALA4399589 | 6.25 | nM | Homo sapiens | ||
3. | ALA4539521 | 2 | Ki | = | 210 | nM | ALA4399589 | 6.68 | nM | Homo sapiens | ||
4. | ALA4453941 | 1 | Ki | = | 6 | nM | ALA4399589 | 8.22 | nM | Homo sapiens | ||
5. | ALA4438748 | 12j | INH | 0 | ALA4379107 | Tde | % | Homo sapiens | ||||
6. | ALA4438748 | 12j | INH | 0 | ALA4379106 | Dose-dependent effect | % | Homo sapiens | ||||
7. | Rho Kinase Inhibitor V | 1 | IC50 | = | 1.5 | nM | ALA4378287 | 8.82 | nM | Homo sapiens | ||
8. | ALA4448462 | ROCK inhibitor IV | IC50 | = | 11.8 | nM | ALA4378287 | 7.93 | nM | Homo sapiens | ||
9. | FASUDIL | HA-1077 | Ki | = | 0.33 | uM | ALA4361952 | 6.48 | nM | Homo sapiens | ||
10. | ALA4465725 | 58 | IC50 | = | 0.094 | uM | ALA4328676 | 7.03 | nM | Homo sapiens | ||
11. | ALA4469434 | 44 | IC50 | = | 0.056 | uM | ALA4328676 | 7.25 | nM | Homo sapiens | ||
12. | ALA4588929 | 30 | IC50 | = | 0.802 | uM | ALA4328676 | 6.10 | nM | Homo sapiens | ||
13. | ALA4556370 | 27 | IC50 | = | 0.963 | uM | ALA4328676 | 6.02 | nM | Homo sapiens | ||
14. | ALA4584824 | 25 | IC50 | = | 7.83 | uM | ALA4328676 | 5.11 | nM | Homo sapiens | ||
15. | ALA4460511 | 24 | IC50 | = | 0.415 | uM | ALA4328676 | 6.38 | nM | Homo sapiens | ||
16. | ALA4459800 | 19 | IC50 | = | 0.116 | uM | ALA4328676 | 6.94 | nM | Homo sapiens | ||
17. | ALA4474946 | 18 | IC50 | = | 0.173 | uM | ALA4328676 | 6.76 | nM | Homo sapiens | ||
18. | ALA4575880 | 17 | IC50 | = | 49.8 | uM | ALA4328676 | 4.30 | nM | Homo sapiens | ||
19. | ROCK inhibitor-2 | 16 | IC50 | = | 0.012 | uM | ALA4328676 | 7.92 | nM | Homo sapiens | ||
20. | ALA4436040 | 14 | IC50 | = | 2.23 | uM | ALA4328676 | 5.65 | nM | Homo sapiens |